According to data compiled by S&P Global Market Intelligence, Recursion Pharmaceuticals (RXRX -3.49%) stock was shedding more than 17% of its value week-to-date as of Thursday night.

“And Just Like That…” Carrie Bradshaw’s latest saga ended exactly as showrunner Michael Patrick King intended, he tells TheWrap ...

Find out how Carrie, Charlotte and Miranda's stories wrapped up in the 'And Just Like That' series finale following season 3 ...

Explore RXRX's upcoming H2'25 trial updates for REC-4881 in familial adenomatous polyposis and REC-617.

The Motley Fool has a disclosure policy. Why Recursion Pharmaceuticals Stock Tanked on Tuesday Person in a lab gazing into a microscope.© Getty Images ...

Clinical-stage biotech Recursion Pharmaceuticals ' (RXRX 1.99%) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving them ...

Recursion Pharmaceuticals is a clinical-stage TechBio company that leverages artificial intelligence (AI), automation, and experimental biology to accelerate the discovery and development of new ...

These new results suggest that we may not need speculative elements to explain the cosmos, but only a deep understanding of gravity and quantum physics.

Entertainment Movies Action Movies DC Movies Superman Superman ending explained: your biggest questions answered on Lex Luthor, the Justice Gang, and what it sets up for the DCU ...

Superman’s Controversial Origin Change Explained (and DCU Storylines It May Set Up) Superman’s DCU origin holds a dark secret.

Does 'Jurassic World Rebirth' have a post credits scene? Here's everything we know about the ending, characters' fates and hints of a sequel ...